96 235

Cited 0 times in

An open-label, multicenter, phase II single arm trial of osimertinib in non-small cell lung cancer patients with uncommon EGFR mutation (KCSG-LU15-09)

Authors
Ahn, MJ | Cho, JH | Sun, JM | Lee, SH | Ahn, JS | Park, K | Park, KU | Kang, EJ | Choi, YH | Kim, KH | An, HJ | Lee, HW
Citation
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 36(15S):9050-9050, 2018
Journal Title
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
ISSN
0732-183X1527-7755
DOI
10.1200/JCO.2018.36.15_suppl.9050
Appears in Collections:
Journal Papers > School of Medicine / Graduate School of Medicine > Hematology-Oncology
Files in This Item:
10.1200_JCO.2018.36.15_suppl.9050.pdfDownload
Export

qrcode

해당 아이템을 이메일로 공유하기 원하시면 인증을 거치시기 바랍니다.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse